Clinical Trial Update: A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing QMF149 to mometasone furoate in asthma completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Mometasone furoate (Mometasone furoate)
• QMF149 (mometasone/formoterol)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2020-03-05